50 employees
Delinia was founded to discover and develop novel therapeutics for the treatment of autoimmune and inflammatory diseases.
2015
$35M
from 2 investors over 2 rounds
Delinia raised $35M on September 14, 2016
Investors: Atlas Venture and Sofinnova Partners